PGA Tour Professional Fred Couples Named Brand Ambassador for Anatabloc™
15 Febrero 2012 - 9:16AM
Business Wire
Rock Creek Pharmaceuticals, Inc., a subsidiary of Star
Scientific, Inc. (NASDAQ: CIGX), today announced that PGA Tour
professional, Fred Couples, is the company’s first Brand Ambassador
for Anatabloc™, its breakthrough product for anti-inflammatory
support. Couples is a 32-year veteran of the PGA Tour, with over 50
professional tournament wins including the Masters (1992), and has
been twice named the PGA Tour Player of the Year (1991, 1992).
“I started taking Anatabloc™, and within a few days, I simply
started feeling better,” said Couples. “There has been a difference
in how I feel, both when I wake up in the morning and throughout my
day. Anatabloc™ was an amazing find for me and I continue to feel
better.”
Introduced in August 2011, Anatabloc™ is a dietary supplement
that assists the body’s natural process for regulating inflammation
using an alkaloid found in plants and vegetables, combined with
Vitamins A and D3 to assist in maintaining healthy levels of
inflammation. Excessive inflammation is associated with a variety
of autoimmune conditions, as well as athletic and work-out
injuries. Anatabloc™ is now available through GNC.com.
“We discovered from golf legend Fred Couples that he had been
taking Anatabloc™ and we were delighted to hear he was feeling
great and seeing real results,” said David Dean, Vice President,
Sales and Marketing, Star Scientific. “Given his stature and
popularity on and off the course, it made absolute sense to ask him
to join our team as a Brand Ambassador. This year marks the 20th
anniversary of Couples’ win at the Masters and he will be playing
in the Tournament. To be in the game at this level and playing this
long is an amazing accomplishment.” Dean added. Couples will wear
the Anatabloc™ logo on his sleeve at all tournaments going
forward.
Couples announced his partnership with Anatabloc™ and his use of
the anti-inflammatory supplement at the Northern Trust Open—a
tournament he almost won in 2011—at the Riviera Country Club in
Pacific Palisades, CA.
“Anatabloc™ should enable millions of Americans, like Fred, to
be more active by maintaining a healthy level of inflammation,”
said Jonnie Williams Sr., Chief Executive Officer, Star Scientific.
“Other professional athletes such as NFL All-Star Jeremy Shockey
and tennis stars Jimmy Arias, Aaron Krickstein, Rob Seguso and
legendary coach Nick Bollettierri are already using Anatabloc™ and
talking about how it is changing their careers as well. We want
everyone to know there is a new way to deal with the aches and
pains associated with excessive inflammation, and the answer is
Anatabloc™,” he added.
“I hope my story will let millions of Americans know that
Anatabloc™ may be an answer in helping them return to an active
lifestyle,” said Couples.
Certain statements contained in this release constitute
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Such statements include,
but are not limited to statements identified by words such as
"believes," "expects," "anticipates," "estimates," "intends,"
"plans," "targets," "projects" and similar expressions. The
statements in this release are based upon the current beliefs and
expectations of our company's management and are subject to
significant risks and uncertainties. Actual results may differ from
those set forth in the forward-looking statements. Numerous factors
could cause or contribute to such differences, including, but not
limited to, the challenges inherent in new product development
initiatives, including the continued development and market
acceptance of our nutraceuticals, our ability to license and
protect our intellectual property, our ability to raise additional
capital in the future that is necessary to maintain our business,
changes in government policy and/or regulation, including with
respect to our nutraceuticals, as well as other risks discussed
from time to time in our filings with the Securities and Exchange
Commission, including, without limitation, our annual report on
Form 10-K for the fiscal year ended December 31, 2010. We undertake
no duty to update any forward-looking statement or any information
contained in this press release or in other public disclosures at
any time.
About Star Scientific
Star Scientific is a technology-oriented company with a mission
to reduce the harm associated with tobacco at every level. It is
engaged in the development of dissolvable smokeless tobacco
products that deliver fewer carcinogenic toxins, principally
through the utilization of the innovative StarCured(R) tobacco
curing technology. Its subsidiary, Rock Creek Pharmaceuticals,
Inc., is involved in the development of nutraceuticals as well as
products to address neurological and mood disorders. Rock Creek
Pharmaceuticals has scientific and research offices in Gloucester,
MA, and a regulatory office in Washington, D.C. Star Scientific has
a Corporate and Sales Office in Glen Allen, VA, an Executive,
Scientific & Regulatory Affairs office in Bethesda, MD, and a
manufacturing facility in Chase City, VA.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50169694&lang=en
Star Scientific, Inc. (MM) (NASDAQ:CIGX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Star Scientific, Inc. (MM) (NASDAQ:CIGX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024